Who founded Sprout Pharmaceuticals?

Sprout Pharmaceuticals was founded by Robert S. Whitehead, Cindy Eckert, Cynthia Whitehead in 2011.

Who are Sprout Pharmaceuticals's investors?

Sprout Pharmaceuticals's investors include Scientia Ventures.

How much funding has Sprout Pharmaceuticals raised?

Sprout Pharmaceuticals has disclosed $59.3M raised across 3 rounds.

Where is Sprout Pharmaceuticals headquartered?

Sprout Pharmaceuticals is headquartered in Raleigh, US.

Sprout Pharmaceuticals

Raleigh, US · Founded 2011 · 1 known investors

Sprout Pharmaceuticals is a pharmaceutical company focused on women's sexual health, known for developing Addyi (flibanserin), the first FDA-approved treatment for low libido in women. It serves patients and healthcare professionals with evidence-based treatments for female sexual dysfunction.

Biotech FemTech Healthtech

Founders & leadership

Sprout Pharmaceuticals was founded in 2011 by Robert S. Whitehead, Cindy Eckert, and Cynthia Whitehead.

Robert S. WhiteheadDirector, Executive Director

Cindy EckertFounder

Cynthia WhiteheadChief Commercial Officer

Anne TomalinVice President, Global Regulatory Affairs

Matthew PetzoldChief Financial Officer and Treasurer

Douglas EckertDirector, Secretary

Josephine TorrenteExecutive Vice President, Corporate and Regulatory Affairs

James PrudenVice President, Manufacturing

Rich FrancoExecutive Vice President, Strategy

James SymonsVice President, Drug Development

Fred PrudenVice President, Manufacturing

Board

W. Robert DahlBoard director

Investors · 1

Scientia VenturesNew York

Reported raises · per SEC filings

Form D private placements

$59.3M disclosed across 3 rounds · 2012–2015

▶$50MraisedJun 2015 · 5 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Anne TomalinExecutive Officer
Anthony WildDirector
Matthew PetzoldExecutive Officer
Douglas EckertExecutive Officer, Director
Robert S. WhiteheadExecutive Officer, Director
Josephine TorrenteExecutive Officer
James PrudenExecutive Officer
Rich FrancoExecutive Officer
Braxton GoodrichDirector
Richard DeSchutterDirector
W. Robert DahlDirector
Trygve MikkelsenDirector
Michael FordDirector
Cynthia WhiteheadExecutive Officer, Director

Offering amount: $50M
Amount sold: $50M
First sale: May 2015
Incorporated: Corporation, Delaware, 2011
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$4.3MraisedJul 2014 · 69 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Trygve MikkelsenDirector
Anne TomalinExecutive Officer
Richard DeSchutterDirector
Robert W. DahlDirector
Douglas EckertExecutive Officer, Director
James PrudenExecutive Officer
Cynthia WhiteheadExecutive Officer, Director
Matthew PetzoldExecutive Officer
Anthony WildDirector
Robert S WhiteheadExecutive Officer, Director
Michael FordDirector
Braxton GoodrichDirector

Offering amount: $15M
Amount sold: $4.3M
Minimum investment: $50K
First sale: Jun 2014
Incorporated: Corporation, Delaware, 2011
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5MraisedMar 2012 · 61 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

James SymonsExecutive Officer
Richard DeSchutterDirector
Robert S. WhiteheadExecutive Officer, Director
Braxton GoodrichDirector
Matthew PetzoldExecutive Officer
Michael FordDirector
Trygve MikkelsenDirector
Douglas EckertExecutive Officer, Director
Cynthia WhiteheadExecutive Officer
Fred PrudenExecutive Officer
W. Robert DahlDirector
Anthony WildDirector

Offering amount: $5M
Amount sold: $5M
Minimum investment: $50K
First sale: Mar 2012
Incorporated: Corporation, Delaware, 2011
Federal exemptions: 06

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Sprout Pharmaceuticals do?: Sprout Pharmaceuticals is a pharmaceutical company focused on women's sexual health, known for developing Addyi (flibanserin), the first FDA-approved treatment for low libido in women. It serves patients and healthcare professionals with evidence-based treatments for female sexual dysfunction.
Who founded Sprout Pharmaceuticals?: Sprout Pharmaceuticals was founded by Robert S. Whitehead, Cindy Eckert, Cynthia Whitehead in 2011.
Who are Sprout Pharmaceuticals's investors?: Sprout Pharmaceuticals's investors include Scientia Ventures.
How much funding has Sprout Pharmaceuticals raised?: Sprout Pharmaceuticals has disclosed $59.3M raised across 3 rounds.
Where is Sprout Pharmaceuticals headquartered?: Sprout Pharmaceuticals is headquartered in Raleigh, US.